Macrophage Nrf1/NFE2L1-Foxo1 axis controls liver fibrosis by modulation of mitochondrial reprogramming
Theranostics · 2026
DOI: 10.7150/thno.112337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Yuanbang Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Tianjin Medical University General Hospital, Tianjin 300052, China. Hauptthemen laut MEDLINE: Liver Cirrhosis, Macrophages, Forkhead Box Protein O1, Mitochondria. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Tianjin Medical University General Hospital, Tianjin 300052, China.
- Central Laboratory, Tianjin Fifth Central Hospital, Tianjin 300450, China.
- Department of Hepatology and Gastroenterology, Tianjin First Central Hospital, Tianjin 300192, China.
- School of Public Health, North China University of Science and Technology, Tangshan 063000, China.
- Department of Anesthesiology, Tianjin First Central Hospital, Tianjin 300192, China.
- College of Life Sciences, State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China.
Zitieren
APA
Lin, Y., Bian, X., Yao, Y., Xu, J., Cao, Y., Wu, Q., Ning, W., Li, L., Sheng, M., & Wang, F. (2026). Macrophage Nrf1/NFE2L1-Foxo1 axis controls liver fibrosis by modulation of mitochondrial reprogramming. Theranostics. https://doi.org/10.7150/thno.112337
Vancouver
Lin Y, Bian X, Yao Y, Xu J, Cao Y, Wu Q, et al. Macrophage Nrf1/NFE2L1-Foxo1 axis controls liver fibrosis by modulation of mitochondrial reprogramming. Theranostics. 2026. doi:10.7150/thno.112337
BibTeX
@article{Lin2026,
author = {Lin, Yuanbang and Bian, Xiyun and Yao, Yao and Xu, Jingman and Cao, Yingli and Wu, Qiong and Ning, Wen and Li, Lian and Sheng, Mingwei and Wang, Fengmei},
title = {Macrophage Nrf1/NFE2L1-Foxo1 axis controls liver fibrosis by modulation of mitochondrial reprogramming},
journal = {Theranostics},
year = {2026},
doi = {10.7150/thno.112337}
}
EUVIMED